DE69514533D1 - Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten - Google Patents
Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonistenInfo
- Publication number
- DE69514533D1 DE69514533D1 DE69514533T DE69514533T DE69514533D1 DE 69514533 D1 DE69514533 D1 DE 69514533D1 DE 69514533 T DE69514533 T DE 69514533T DE 69514533 T DE69514533 T DE 69514533T DE 69514533 D1 DE69514533 D1 DE 69514533D1
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- hydrogen
- amino
- alkoxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940122459 Glutamate antagonist Drugs 0.000 title 1
- 239000003194 amino acid receptor blocking agent Substances 0.000 title 1
- 150000002475 indoles Chemical class 0.000 title 1
- 150000003252 quinoxalines Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- -1 hydroxy, amino Chemical group 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical group O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000005605 benzo group Chemical group 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK105494 | 1994-09-14 | ||
| PCT/EP1995/003594 WO1996008495A1 (en) | 1994-09-14 | 1995-09-12 | Fused indole and quinoxaline derivatives, their preparation and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69514533D1 true DE69514533D1 (de) | 2000-02-17 |
| DE69514533T2 DE69514533T2 (de) | 2000-07-06 |
Family
ID=8100467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69514533T Expired - Lifetime DE69514533T2 (de) | 1994-09-14 | 1995-09-12 | Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5801174A (de) |
| EP (1) | EP0781285B1 (de) |
| JP (1) | JP3164372B2 (de) |
| AT (1) | ATE188701T1 (de) |
| AU (1) | AU686888B2 (de) |
| CA (1) | CA2199614C (de) |
| DE (1) | DE69514533T2 (de) |
| EE (1) | EE03772B1 (de) |
| FI (1) | FI112486B (de) |
| NO (1) | NO308851B1 (de) |
| NZ (1) | NZ293266A (de) |
| WO (1) | WO1996008495A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA54403C2 (uk) * | 1996-10-01 | 2003-03-17 | Н'Юросерч А/С | Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму |
| FR2781482B1 (fr) * | 1998-07-27 | 2001-08-31 | Adir | Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2000071102A2 (en) * | 1999-05-19 | 2000-11-30 | Neurosearch A/S | Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders |
| ES2266214T3 (es) | 2000-01-24 | 2007-03-01 | Neurosearch A/S | Derivados de isatina con actividad neurotrofica. |
| JP2009516712A (ja) | 2005-11-23 | 2009-04-23 | ペインセプター ファーマ コーポレーション | 依存性イオンチャネルを調節するための組成物および方法 |
| CA2632027A1 (en) | 2005-12-14 | 2007-06-21 | Amgen Inc. | Diaza heterocyclic sulfonamide derivatives and their uses |
| US20080004306A1 (en) * | 2006-04-10 | 2008-01-03 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| US20090246134A1 (en) * | 2007-05-30 | 2009-10-01 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| CN104271749A (zh) | 2012-04-18 | 2015-01-07 | 雷蒙特亚特特拉维夫大学有限公司 | 用于递送核酸的脂化的糖胺聚糖颗粒 |
| WO2016114655A1 (en) * | 2015-01-12 | 2016-07-21 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
| WO2017065602A1 (en) * | 2015-10-13 | 2017-04-20 | Ry Pharma B.V. | Treating neuromuscular or neurologic disease through reducing gabaergic and/or glycinergic inhibitory neurotransmitter overstimulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9204914A (es) * | 1991-08-28 | 1993-07-01 | Frank Watjen | Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende. |
| DK0664807T3 (da) * | 1992-10-13 | 1998-04-27 | Warner Lambert Co | Quinoxalindionderivater som EAA-antagonister |
-
1995
- 1995-09-12 CA CA002199614A patent/CA2199614C/en not_active Expired - Fee Related
- 1995-09-12 EE EE9700051A patent/EE03772B1/xx not_active IP Right Cessation
- 1995-09-12 EP EP95932730A patent/EP0781285B1/de not_active Expired - Lifetime
- 1995-09-12 US US08/809,086 patent/US5801174A/en not_active Expired - Lifetime
- 1995-09-12 WO PCT/EP1995/003594 patent/WO1996008495A1/en active IP Right Grant
- 1995-09-12 JP JP50990896A patent/JP3164372B2/ja not_active Expired - Fee Related
- 1995-09-12 NZ NZ293266A patent/NZ293266A/en unknown
- 1995-09-12 AU AU35665/95A patent/AU686888B2/en not_active Ceased
- 1995-09-12 DE DE69514533T patent/DE69514533T2/de not_active Expired - Lifetime
- 1995-09-12 AT AT95932730T patent/ATE188701T1/de not_active IP Right Cessation
-
1997
- 1997-02-25 FI FI970785A patent/FI112486B/fi active
- 1997-02-27 NO NO970903A patent/NO308851B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO308851B1 (no) | 2000-11-06 |
| NO970903D0 (no) | 1997-02-27 |
| ATE188701T1 (de) | 2000-01-15 |
| CA2199614A1 (en) | 1996-03-21 |
| NZ293266A (en) | 1998-01-26 |
| EE9700051A (et) | 1997-08-15 |
| WO1996008495A1 (en) | 1996-03-21 |
| AU3566595A (en) | 1996-03-29 |
| CA2199614C (en) | 2000-02-22 |
| JPH09511525A (ja) | 1997-11-18 |
| EP0781285A1 (de) | 1997-07-02 |
| AU686888B2 (en) | 1998-02-12 |
| DE69514533T2 (de) | 2000-07-06 |
| EE03772B1 (et) | 2002-06-17 |
| NO970903L (no) | 1997-05-07 |
| US5801174A (en) | 1998-09-01 |
| FI970785A (fi) | 1997-03-13 |
| FI970785A0 (fi) | 1997-02-25 |
| FI112486B (fi) | 2003-12-15 |
| EP0781285B1 (de) | 2000-01-12 |
| JP3164372B2 (ja) | 2001-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA50767C2 (uk) | Похідні індолу, що використовуються як антагоністи рецептора ендотеліну, спосіб їх одержання, фармацевтична композиція та спосіб лікування | |
| DE69514533D1 (de) | Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten | |
| DK0858461T3 (da) | Kondenserede tropanderivater som neurotransmittergenoptagelsesinhibitorer | |
| EA200401282A1 (ru) | Пиридиноилпиперидины как агонисты 5-ht1f | |
| ATE275545T1 (de) | Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d | |
| AR015036A1 (es) | Derivados de indolilo antisicoticos, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento | |
| PE20011212A1 (es) | Compuestos para el tratamiento de la fibromialgia y el sindrome de fatiga cronica | |
| NZ528997A (en) | Sulfonamides | |
| ATE161259T1 (de) | Ampa antagonisten und behandlungsmethode | |
| HUP9700595A1 (hu) | Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása | |
| DE69514532D1 (de) | Indol-2,3-dione-3-oximderivate, ihre herstellung und verwendung | |
| DK1523486T3 (da) | Tetracykliske arylsulfonylindoler med serotoninreceptor-affinitet | |
| MXPA04005077A (es) | Derivados de benzotiazol. | |
| DE69902766D1 (de) | N-aryloxyethylaminderivate zur behandlung der depression | |
| ATE214069T1 (de) | Heterocyclische verbindungen und ihre herstellung und verwendung | |
| DE69510510D1 (de) | N-benzoylmethylsubstituierte paroxetinderivate | |
| ATE193705T1 (de) | 4-p-fluorbenzoyl-1-piperidinyl-propoxy-chromen- - on derivate, deren herstellung und deren verwendung zur behandlung von psychosen und schizophrenie | |
| HUP9800889A1 (hu) | Új naftil-piperazin-származékok | |
| DE60009932D1 (de) | 5-aminoalkyl- und 5-aminocarbonylsubstituierte indole | |
| TH50283A (th) | อนุพันธ์ 5-ฟีนิล-ไพริมิดีน | |
| DE69013461D1 (de) | 1,3,4-Trisubstituierte Azetidin-2-on-Derivate, zur beta-Lactam-Synthese nützliche Zwischenprodukte und deren Verfahren zur asymmetrischen Herstellung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |